BioAtla, Inc. (BCAB)
NASDAQ: BCAB · IEX Real-Time Price · USD
2.350
+0.110 (4.91%)
At close: Apr 24, 2024, 4:00 PM
2.460
+0.110 (4.68%)
Pre-market: Apr 25, 2024, 8:38 AM EDT
BioAtla Market Cap
BioAtla has a market cap or net worth of $113.03 million as of April 25, 2024. Its market cap has decreased by -37.86% in one year.
Market Cap
113.03M
Enterprise Value
4.02M
1-Year Change
-37.86%
Ranking
Category
Stock Price
$2.35
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $113.03M, a decrease of -80.43%. That is a compound annual growth rate of -38.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2024 | 107.70M | 2.67% |
| Apr 22, 2024 | 104.90M | 3.66% |
| Apr 19, 2024 | 101.20M | -13.43% |
| Apr 18, 2024 | 116.90M | -3.94% |
| Apr 17, 2024 | 121.70M | -3.64% |
| Apr 16, 2024 | 126.30M | -8.21% |
| Apr 15, 2024 | 137.60M | -8.57% |
| Apr 12, 2024 | 150.50M | -6.58% |
| Apr 11, 2024 | 161.10M | 3.07% |
| Apr 10, 2024 | 156.30M | -8.97% |
| Apr 9, 2024 | 171.70M | -6.79% |
| Apr 8, 2024 | 184.20M | 0.77% |
| Apr 5, 2024 | 182.80M | -3.02% |
| Apr 4, 2024 | 188.50M | 5.90% |
| Apr 3, 2024 | 178.00M | 5.14% |
| Apr 2, 2024 | 169.30M | 3.87% |
| Apr 1, 2024 | 163.00M | -1.51% |
| Mar 28, 2024 | 165.50M | -0.54% |
| Mar 27, 2024 | 166.40M | 14.92% |
| Mar 26, 2024 | 144.80M | 29.63% |
| Mar 25, 2024 | 111.70M | -3.29% |
| Mar 22, 2024 | 115.50M | - |
| Mar 21, 2024 | 115.50M | 1.23% |
| Mar 20, 2024 | 114.10M | -3.22% |
| Mar 19, 2024 | 117.90M | 5.08% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seer, Inc. | 114.97M |
| Citius Pharmaceuticals | 114.71M |
| Aurora Cannabis | 113.55M |
| Emergent BioSolutions | 113.02M |
| Immunic | 112.41M |
| CytomX Therapeutics | 111.06M |
| Neuronetics | 110.25M |
| TELA Bio | 109.46M |